Severe asthma remains active in most despite widespread biologic treatment

Severe asthma affects around 5%–10% of all people with asthma and can involve recurrent exacerbations, impaired lung function and the need for corticosteroid treatment. In recent years, biologic therapies have improved treatment options for many patients.

≈